Regenerative Medicine for Joint Pain in Orlando

PrimeCell Regenerative · Orlando

Regenerative Medicine for Joint Pain in Orlando

Joint pain can make walking, exercise, sleep, and everyday activities feel increasingly difficult. PrimeCell provides physician-led evaluations and individualized treatment plans for knee, hip, shoulder, ankle, hand, and other joint conditions.

Joint Pain Is a Symptom, Not a Diagnosis


Joint discomfort may come from osteoarthritis, cartilage degeneration, inflammation, previous injury, tendon dysfunction, ligament instability, altered mechanics, or more than one problem at the same time.

An X-ray or MRI can provide valuable information, but an imaging finding does not always identify the structure responsible for symptoms. Treatment begins with a focused history, physical examination, review of available imaging, and an assessment of how the condition affects movement and function.

Conditions We Evaluate


A consultation may be appropriate for selected patients with persistent joint pain or reduced function related to:

  • Knee, hip, shoulder, ankle, hand, or wrist osteoarthritis
  • Patellofemoral joint pain
  • Meniscus- or labrum-related symptoms
  • Persistent joint inflammation or stiffness
  • Pain following a previous injury or procedure
  • Degenerative changes that continue despite conservative care
  • Joint pain with weakness, restricted movement, or reduced activity tolerance

How Regenerative Medicine May Support Joint Health


Regenerative and orthobiologic procedures are intended to influence the environment surrounding an injured or degenerative joint. Depending on the diagnosis and treatment selected, the goals may include:

  • Modulating excessive inflammatory activity
  • Supporting the joint’s natural healing response
  • Improving the environment surrounding cartilage and connective tissue
  • Reducing pain and stiffness
  • Improving mobility and tolerance for rehabilitation
  • Delaying more invasive treatment when clinically appropriate

Treatment Options May Include


Take the Next Step Toward Better Joint Function

Platelet-Rich Plasma (PRP)

Prepared from the patient’s own blood, PRP contains concentrated platelets and signaling proteins involved in the body’s repair response and may be considered for selected joint, tendon, and ligament conditions.

Platelet-Rich Fibrin (PRF)

Another autologous blood-derived preparation whose composition and processing differ from traditional PRP; its use should be matched to the clinical objective.

Other Orthobiologic Procedures

Depending on the diagnosis, a treatment discussion may include prolotherapy or other biologically oriented procedures designed to support the local tissue environment. Musculoskeletal ultrasound may be used to visualize the targeted anatomy and guide selected procedures for accurate needle placement.

Cellular, tissue-derived, or exosome products have different compositions, processing methods, regulatory classifications, and levels of evidence. They are not FDA-approved to treat osteoarthritis or joint pain and should be discussed with clear informed consent.

A comprehensive plan may also include therapeutic exercise, physical therapy, strength and mobility training, activity modification, weight-management support, bracing, medication review, established injections, or surgical consultation when appropriate.

A Thoughtful, Diagnosis-First Decision


A consultation may be appropriate for patients with a confirmed or suspected joint condition who continue to experience symptoms despite conservative care, want to explore non-surgical options, and understand that improvement cannot be guaranteed. There is no single success rate that applies to every joint or procedure—results may be influenced by severity, alignment, age, health, body weight, strength, previous treatment, rehabilitation, and individual response. Some patients experience meaningful improvement; others experience temporary, limited, or no improvement, often developing gradually over weeks or months.

Regenerative treatments involving stem cells, exosomes, Wharton’s Jelly, umbilical-cord-derived products, or other human cellular and tissue-based products may be investigational for osteoarthritis and other joint conditions and may not be approved by the U.S. FDA for these uses. No guarantee is made regarding individual outcomes. Potential benefits, risks, alternatives, product sourcing, regulatory status, evidence, and financial responsibilities should be reviewed during an individualized medical consultation.

Take the Next Step Toward Better Joint Function

Joint pain does not always mean surgery is the only option. A comprehensive evaluation may help identify the source of your symptoms and clarify which strategy may be appropriate.